These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 16280250

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study.
    Chung S, Ceja H, Gawłowicz J, McShea C, Schiemann J, Lu S.
    Epilepsy Res; 2016 Feb; 120():7-12. PubMed ID: 26716580
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Levetiracetam as add-on therapy in generalised epilepsies.
    Kumar SP, Smith PE.
    Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
    [Abstract] [Full Text] [Related]

  • 33. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ, Kelly K, Parker P, Brodie MJ.
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
    Ben-Menachem E, Falter U.
    Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.